FDA Oks Glaxo's Flonase Allergy Relief for Sale Over The Counter in US
July 24 2014 - 01:22PM
Dow Jones News
By Razak Musah Baba
LONDON--GlaxoSmithKline PLC (GSK.LN) said Thursday that the U.S.
Food and Drug Administration has approved Flonase Allergy Relief as
an over-the-counter treatment for temporary relief of the symptoms
of hay fever or upper respiratory allergies.
The U.K. drug maker said Flonase Allergy Relief will be
available over the counter in early 2015.
GlaxoSmithKline shares closed Thursday at GBP14.70, valuing the
company at GBP71.25 billion.
Write to Razak Musah Baba at razak.baba@wsj.com; Twitter:
@Raztweet
Subscribe to WSJ: http://online.wsj.com?mod=djnwires
Gsk (LSE:GSK)
Historical Stock Chart
From Feb 2024 to Mar 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2023 to Mar 2024